CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
esophageal cooling device (Attune Medical, Chicago, IL)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04063761
NCT04063761N/ACompleted

Evaluating Active Esophageal Cooling During Cardiac Ablation Procedures

Advanced Cooling Therapy, Inc., d/b/a Attune Medical·interventional·Posted Aug 21, 2019·Updated Jun 17, 2025

In Brief

A clinical study evaluating esophageal cooling device (Attune Medical, Chicago, IL) for Atrial Fibrillation. Completed, enrolled 20 participants across 1 site.

Detailed Summary

Left atrial catheter ablation including pulmonary vein isolation is a standard therapy in the management of symptomatic atrial fibrillation; however thermal esophageal injury is a known potential consequence of this procedure. Delivery of radiofrequency (RF) energy necessary to perform left atrial ablation has the potential to cause injury to the nearby esophagus including ulceration, hematoma, spasm, esophageal motility disorders, and, in the most extreme case, atrial-esophageal fistula (AEF). Esophageal mucosal lesions are the likely precursor to AEF, and esophageal mucosal lesions have been detected on post-ablation endoscopy after pulmonary vein isolation with an incidence ranging from 3% to 60%. Active esophageal cooling during RF ablation as a means of esophageal injury prevention has been investigated through mathematical models, pre-clinical studies, and in clinical trials. Existing data support the efficacy of this approach, but the practice has not been widely adopted due to lack of a commercially available device. The aim or purpose of this study is to evaluate the impact on procedural efficiency of ablation procedures performed using esophageal heat transfer to cool the esophagus during left atrial RF ablation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsUniversity of Iowa

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedAug 21, 2019
Enrollment StartJun 20, 2019
Primary CompletionFeb 1, 2021
Study CompletionFeb 20, 2021
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 6.9 years ago

Interventions

esophageal cooling device (Attune Medical, Chicago, IL)device

Prospective, single center pilot study